Amyloidosis in continuous ambulatory peritoneal dialysis.

Paediatric continuous ambulatory peritoneal dialysis.

Ten children in end-stage renal failure were treated by continuous ambulatory peritoneal dialysis (CAPD). This represents a total of 3.4 patient years. Biochemical control was good, and parent and patient acceptability high. Peritonitis was the chief complication, but after the institution of a specific CAPD education and training programme the incidence declined 10-fold. We regard CAPD as an e...

Current problems in continuous ambulatory peritoneal dialysis

In spite of multiple problems, continuous ambulatory peritoneal dialysis is now an acceptable alternative treatment for end-stage renal failure. With proper care and attention to detail, many of its problems can be reduced or eliminated. It is particularly suitable for the very old, the very young and the patient living a long distance from the centre, and it is the treatment of choice for diab...

Fungal peritonitis in continuous ambulatory peritoneal dialysis.

Fungal peritonitis represents one of the most serious complications in patients on peritoneal dialysis (CAPD). The therapy often consists of peritoneal catheter extraction and patient recruitment to hemodialysis. For some of the patients the peritoneal dialysis is the only way of dialysis, due to inability to perform a permanent vascular access. In this study we present 13 patients with fungal ...

Continuous ambulatory peritoneal dialysis in India.

Amikacin pharmacokinetics during continuous ambulatory peritoneal dialysis.

The pharmacokinetics of amikacin were investigated in five stable patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Each patient was studied after the administration of 7.5 mg of amikacin per kg by both the intravenous (i.v.) and intraperitoneal (i.p.) route, allowing a 1-month washout period between doses. No differences in amikacin half-life, volume of distribution, total ...